logo
Plus   Neg
Share
Email

Alexion Pharma Raises 2019 Outlook

Alexion Pharmaceuticals Inc. (ALXN) increased its revenues and earnings per share guidance for fiscal year 2019.

The company raised its fiscal year 2019 earnings per share outlook to a range of $8.58 to $8.78 from the prior estimation of $8.13 to $8.41 per share. It also increased its non-GAAP earnings per share guidance to a range of $10.25 to $10.40 from the previous outlook of $9.65 to $9.85 per share. Analysts polled by Thomson Reuters expect the company to report earnings of $9.94 per share for fiscal year 2019. Analysts' estimates typically exclude special items.

The company now projects total revenues for fiscal year 2019 to be $4.860 billion to $4.890 billion, compared to the prior outlook of $4.750 billion to $4.800 billion. Analysts expect revenues of $4.85 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Golden Pearl Trading Corp. is recalling certain ready-to-eat or RTE imported Siluriformes products that were produced without benefit of import inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves around 12,054 pounds of Siluriformes products that were not presented for import re-inspection into the United States. The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from...
Follow RTT
>